Literature DB >> 1639064

The human p50csk tyrosine kinase phosphorylates p56lck at Tyr-505 and down regulates its catalytic activity.

M Bergman1, T Mustelin, C Oetken, J Partanen, N A Flint, K E Amrein, M Autero, P Burn, K Alitalo.   

Abstract

Protein tyrosine kinases participate in the transduction and modulation of signals that regulate proliferation and differentiation of cells. Excessive or deregulated protein tyrosine kinase activity can cause malignant transformation. The catalytic activity of the T cell protein tyrosine kinase p56lck is normally suppressed by phosphorylation of a carboxyl-terminal tyrosine, Tyr-505, by another cellular protein tyrosine kinase. Here we characterize a human cytosolic 50 kDa protein tyrosine kinase, p50csk, which specifically phosphorylates Tyr-505 of p56lck and a synthetic peptide containing this site. Phosphorylation of Tyr-505 suppressed the catalytic activity of p56lck. We suggest that p50csk negatively regulates p56lck, and perhaps other cellular src family kinases.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1639064      PMCID: PMC556773          DOI: 10.1002/j.1460-2075.1992.tb05361.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  50 in total

1.  Neoplastic transformation induced by an activated lymphocyte-specific protein tyrosine kinase (pp56lck).

Authors:  J D Marth; J A Cooper; C S King; S F Ziegler; D A Tinker; R W Overell; E G Krebs; R M Perlmutter
Journal:  Mol Cell Biol       Date:  1988-02       Impact factor: 4.272

2.  p56lck protein-tyrosine kinase is cytoskeletal and does not bind to polyomavirus middle T antigen.

Authors:  R R Louie; C S King; A MacAuley; J D Marth; R M Perlmutter; W Eckhart; J A Cooper
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

3.  Enchancement of the infectivity of simian virus 40 deoxyribonucleic acid with diethylaminoethyl-dextran.

Authors:  J H McCutchan; J S Pagano
Journal:  J Natl Cancer Inst       Date:  1968-08       Impact factor: 13.506

4.  A human T cell-specific cDNA clone (YT16) encodes a protein with extensive homology to a family of protein-tyrosine kinases.

Authors:  Y Koga; N Caccia; B Toyonaga; R Spolski; Y Yanagi; Y Yoshikai; T W Mak
Journal:  Eur J Immunol       Date:  1986-12       Impact factor: 5.532

Review 5.  Do CD4 and CD8 control T-cell activation via a specific tyrosine protein kinase?

Authors:  T Mustelin; A Altman
Journal:  Immunol Today       Date:  1989-06

6.  The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lck.

Authors:  A Veillette; M A Bookman; E M Horak; J B Bolen
Journal:  Cell       Date:  1988-10-21       Impact factor: 41.582

7.  yes-related protooncogene, syn, belongs to the protein-tyrosine kinase family.

Authors:  K Semba; M Nishizawa; N Miyajima; M C Yoshida; J Sukegawa; Y Yamanashi; M Sasaki; T Yamamoto; K Toyoshima
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

8.  Characterization of the protein apparently responsible for the elevated tyrosine protein kinase activity in LSTRA cells.

Authors:  A F Voronova; J E Buss; T Patschinsky; T Hunter; B M Sefton
Journal:  Mol Cell Biol       Date:  1984-12       Impact factor: 4.272

9.  Covalently bound myristate in a lymphoma tyrosine protein kinase.

Authors:  G A Marchildon; J E Casnellie; K A Walsh; E G Krebs
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

10.  Mutation of a site of tyrosine phosphorylation in the lymphocyte-specific tyrosine protein kinase, p56lck, reveals its oncogenic potential in fibroblasts.

Authors:  K E Amrein; B M Sefton
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

View more
  86 in total

Review 1.  Membrane domains and the immunological synapse: keeping T cells resting and ready.

Authors:  Michael L Dustin
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

Review 2.  Positive and negative regulation of T-cell activation through kinases and phosphatases.

Authors:  Tomas Mustelin; Kjetil Taskén
Journal:  Biochem J       Date:  2003-04-01       Impact factor: 3.857

3.  PKC-θ: hitting the bull's eye.

Authors:  Michael L Dustin
Journal:  Nat Immunol       Date:  2011-10-19       Impact factor: 25.606

4.  Transforming growth factor β (TGF-β) receptor signaling regulates kinase networks and phosphatidylinositol metabolism during T-cell activation.

Authors:  Richard T Cattley; Mijoon Lee; William C Boggess; William F Hawse
Journal:  J Biol Chem       Date:  2020-05-01       Impact factor: 5.157

Review 5.  The Contribution of PTPN22 to Rheumatic Disease.

Authors:  Tomas Mustelin; Nunzio Bottini; Stephanie M Stanford
Journal:  Arthritis Rheumatol       Date:  2019-03-02       Impact factor: 10.995

6.  Removal of C-terminal SRC kinase from the immune synapse by a new binding protein.

Authors:  Souad Rahmouni; Torkel Vang; Andres Alonso; Scott Williams; Marianne van Stipdonk; Chiara Soncini; Michel Moutschen; Stephen P Schoenberger; Tomas Mustelin
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

7.  Suppression of c-Src activity by C-terminal Src kinase involves the c-Src SH2 and SH3 domains: analysis with Saccharomyces cerevisiae.

Authors:  S M Murphy; M Bergman; D O Morgan
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

8.  SOCS-6 negatively regulates T cell activation through targeting p56lck to proteasomal degradation.

Authors:  Young Bong Choi; Myoungsun Son; Mijin Park; Jaekyoon Shin; Yungdae Yun
Journal:  J Biol Chem       Date:  2009-12-10       Impact factor: 5.157

9.  The nonreceptor protein-tyrosine kinase CSK complexes directly with the GTPase-activating protein-associated p62 protein in cells expressing v-Src or activated c-Src.

Authors:  K Neet; T Hunter
Journal:  Mol Cell Biol       Date:  1995-09       Impact factor: 4.272

Review 10.  The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection.

Authors:  S Bour; R Geleziunas; M A Wainberg
Journal:  Microbiol Rev       Date:  1995-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.